Cargando…
Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study
BACKGROUND: The administration of anticancer drugs in females with comorbidity increases the risk for cancer therapy-related cardiovascular toxicity (CTR-CVT), which in turn contributes to cardiovascular disease (CVD). Furthermore, a pathophysiological connection between cancer and cardiovascular di...
Autores principales: | Hubbert, Laila, Mallios, Panagiotis, Karlström, Patric, Papakonstantinou, Andri, Bergh, Jonas, Hedayati, Elham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154463/ https://www.ncbi.nlm.nih.gov/pubmed/37152049 http://dx.doi.org/10.3389/fonc.2023.1095251 |
Ejemplares similares
-
Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer
por: Altena, Renske, et al.
Publicado: (2021) -
Approaches to management of cardiovascular morbidity in adult cancer patients – cross-sectional survey among cardio-oncology experts
por: Hedayati, E., et al.
Publicado: (2020) -
Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2023) -
Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies
por: Altena, Renske, et al.
Publicado: (2022) -
Cardiovascular Toxicities from Systemic Breast Cancer Therapy
por: Guo, Shuang, et al.
Publicado: (2014)